Very scarce data exist regarding the relationship between differential white blood cell (WBC) counts and primary arteriovenous fistula (AVF) failure. Thus, the current study aimed to investigate the specific relationship between primary AVF failure and differential WBC counts.
Methods
Sociodemographic, clinical, and laboratory parameters including automatically determined complete blood counts of the patients (from medical records and hospital charts) prior to AVF fistula surgery were recorded. Primary AVF failure was described as a complication of the AVF before the first successful cannulation for HD treatment.
Results
In total 94 patients (Male/Female: 49/45, Aged: 50.9 ∓ 15.0 years) were included. Ferritin, high sensitive C-reactive protein (hs-crp), total WBC count, neutrophil count, red cell distribution width (RDW) were higher in patients with primary AVF failure compared to patients without primary AVF failure. Logistic regression analysis showed that presence of diabetes (OR = 3.654, p = 0.035), RDW (OR = 0.449, p = 0.033) and ferritin (OR = 1.097, p = 0.021) were independently related with primary AVF failure.
Conclusions
Neither total WBC counts nor WBC subtypes were related with primary AVF failure. Higher RDW and ferritin levels had a prognostic value for development of primary AVF failure.
AfsarB., ElsurerR.. The primary arteriovenous fistula failure-a comparison between diabetic and non-diabetic patients: glycemic control matters.Int Urol Nephrol.2012; 44(2): 575–581.
2.
Roy-ChaudhuryP., ArendL., ZhangJ.. Neointimal hyperplasia in early arteriovenous fistula failure.Am J Kidney Dis.2007; 50(5): 782–790.
3.
Roy-ChaudhuryP., WangY., KrishnamoorthyM.. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access.Nephrol Dial Transplant.2009; 24(9): 2786–2791.
4.
RekhterM.D., GordonD.. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques.Am J Pathol.1995; 147(3): 668–677.
LiuB.C., LiL., GaoM., WangY.L., YuJ.R.. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis.Chin Med J (Engl).2008; 121(21): 2157–2161.
7.
PasceriV., ChengJ.S., WillersonJ.T., YehE.T.. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.Circulation.2001; 103(21): 2531–2534.
8.
GagliardiG.M., RossiS., CondinoF.. Malnutrition, infection and arteriovenous fistula failure: is there a link?J Vasc Access.2011; 12(1): 57–62.
9.
MarchesiniG., ForlaniG., CerrelliF.. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes.Diabet Med.2004; 21(4): 383–387.
10.
ColiL., DonatiG., CappuccilliM.L.. Role of the hemodialysis vascular access type in inflammation status and monocyte activation.Int J Artif Organs.2011; 34(6): 481–488.
11.
ChangC.J., KoY.S., KoP.J.. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity.Kidney Int.2005; 68(3): 1312–1319.
12.
HayakawaY., TakemuraG., MisaoJ.. Apoptosis and overexpression of bax protein and bax mRNA in smooth muscle cells within intimal hyperplasia of human radial arteries: analysis with arteriovenous fistulas used for hemodialysis.Arterioscler Thromb Vasc Biol.1999; 19(9): 2066–2077.
13.
RossR.. The pathogenesis of atherosclerosis: a perspective for the 1990s.Nature.1993; 362(6423): 801–809.
14.
EjerbladS., EricssonJ.L.E., ErikssonI.. Arterial lesions of the radial artery in uraemic patients.Acta Chir Scand.1979; 145(6): 415–428.
15.
GirerdX., LondonG., BoutouyrieP., MouradJ.J., SafarM., LaurentS.. Remodeling of the radial artery in response to a chronic increase in shear stress.Hypertension.1996; 27(3 Pt 2): 799–803.
16.
ReddanD.N., KlassenP.S., SzczechL.A.. White blood cells as a novel mortality predictor in haemodialysis patients.Nephrol Dial Transplant.2003; 18(6): 1167–1173.
17.
PiferT.B., McCulloughK.P., PortF.K.. Mortality risk in he-modialysis patients and changes in nutritional indicators: DOPPS.Kidney Int.2002; 62(6): 2238–2245.
18.
StenvinkelP., KettelerM., JohnsonR.J.. IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly.Kidney Int.2005; 67(4): 1216–1233.
19.
DzabicM., BojakowskiK., KurzejamskaE.. Significance of cytomegalovirus infection in the failure of native arteriovenous fistula.Clin Microbiol Infect.2012; 18(1): E5–E7.
20.
MorenaM., BoscJ.Y., JaussentI.. The role of mineral metabolism and inflammation on dialysis vascular access failure.J Vasc Access.2006; 7(2): 77–82.
21.
BojakowskiK., DzabicM., KurzejamskaE.. A high red blood cell distribution width predicts failure of arteriovenous fistula.PLoS One.2012; 7(5): e36482.
LippiG., TargherG., MontagnanaM., SalvagnoG.L., ZoppiniG., GuidiG.C.. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients.Arch Pathol Lab Med.2009; 133(4): 628–632.
24.
PackardR.R., LibbyP.. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.Clin Chem.2008; 54(1): 24–38.
25.
KalayN., AytekinM., KayaM.G.. The relationship between inflammation and slow coronary flow: increased red cell distribution width and serum uric acid levels.Turk Kardiyol Dern Ars.2011; 39(6): 463–468.
26.
YeZ., SmithC., KulloI.J.. Usefulness of Red Cell Distribution Width to Predict Mortality in Patients with Peripheral Artery Disease.Am J Cardiol.2011; 107(8): 1241–1245.
27.
KiechlS., WilleitJ., EggerG., PoeweW., OberhollenzerF.. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study.Circulation.1997; 96(10): 3300–3307.
28.
LeeK.R., SweeneyG., KimW.Y., KimK.K.. Serum ferritin is linked with aortic stiffness in apparently healthy Korean women.Crit Pathw Cardiol.2010; 9(3): 160–163.
29.
HuijbregtsH.J., BotsM.L., WittensC.H., SchramaY.C., MollF.L., BlankestijnPJ; CIMINO study group. Hemodialysis arterio-venous fistula patency revisited: results of a prospective, multicenter initiative.Clin J Am Soc Nephrol.2008; 3(3): 714–719.
30.
LinS.L., HuangC.H., ChenH.S., HsuW.A., YenC.J., YenT.S.. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas.Am J Nephrol.1998; 18(2): 96–100.
31.
KonnerK.. Primary vascular access in diabetic patients: an audit.Nephrol Dial Transplant.2000; 15(9): 1317–1325.
